PT1261355E - Formulacao de hidrato de carbono (adjuvante prebiotico) para aumentar a resposta imune - Google Patents

Formulacao de hidrato de carbono (adjuvante prebiotico) para aumentar a resposta imune

Info

Publication number
PT1261355E
PT1261355E PT01903767T PT01903767T PT1261355E PT 1261355 E PT1261355 E PT 1261355E PT 01903767 T PT01903767 T PT 01903767T PT 01903767 T PT01903767 T PT 01903767T PT 1261355 E PT1261355 E PT 1261355E
Authority
PT
Portugal
Prior art keywords
immune response
carbon hydrate
increase immune
hydrate formulation
prebiotic
Prior art date
Application number
PT01903767T
Other languages
English (en)
Inventor
Florence Rochat
Anne-Lise Carrie
Zdenek Kratky
Haschke Ferdinand
Link-Amster Harriet
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PT1261355E publication Critical patent/PT1261355E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT01903767T 2000-03-01 2001-02-14 Formulacao de hidrato de carbono (adjuvante prebiotico) para aumentar a resposta imune PT1261355E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
PT1261355E true PT1261355E (pt) 2005-02-28

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01903767T PT1261355E (pt) 2000-03-01 2001-02-14 Formulacao de hidrato de carbono (adjuvante prebiotico) para aumentar a resposta imune

Country Status (22)

Country Link
US (2) US20030040492A1 (pt)
EP (1) EP1261355B1 (pt)
JP (1) JP4838477B2 (pt)
KR (1) KR20020081375A (pt)
CN (1) CN1243551C (pt)
AR (1) AR027968A1 (pt)
AT (1) ATE283697T1 (pt)
AU (2) AU2001231746C1 (pt)
BR (1) BR0108828A (pt)
CA (1) CA2400969C (pt)
DE (1) DE60107544T2 (pt)
ES (1) ES2232591T3 (pt)
HK (1) HK1051650A1 (pt)
HU (1) HUP0204546A3 (pt)
IL (1) IL151280A0 (pt)
MX (1) MXPA02008447A (pt)
NO (1) NO20024011D0 (pt)
PL (1) PL365136A1 (pt)
PT (1) PT1261355E (pt)
UA (1) UA73763C2 (pt)
WO (1) WO2001064225A1 (pt)
ZA (1) ZA200207849B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20100055083A1 (en) * 2006-10-18 2010-03-04 Ray Edward Kowalski Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20110104335A1 (en) * 2007-08-24 2011-05-05 Luc Rumbaut Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
PL3342413T3 (pl) 2009-07-15 2022-03-28 N.V. Nutricia Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej
CN104206946A (zh) 2009-11-12 2014-12-17 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
WO2017021413A1 (en) * 2015-08-04 2017-02-09 Südzucker AG Prophylactic use of inulin against sinusitis
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
BR112020004264A2 (pt) 2017-09-08 2020-10-06 Evelo Biosciences, Inc. vesículas extracelulares bacterianas
AU2018330323A1 (en) * 2017-09-08 2020-03-19 Evelo Biosciences, Inc. Extracellular vesicles from Prevotella
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002679A1 (en) * 1985-10-31 1987-05-07 The Australian National University Immunotherapeutic treatment
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise Sa Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
MXPA02008447A (es) 2002-12-13
NO20024011L (no) 2002-08-22
EP1261355A1 (en) 2002-12-04
CA2400969C (en) 2011-04-19
US20040191234A1 (en) 2004-09-30
CA2400969A1 (en) 2001-09-07
IL151280A0 (en) 2003-04-10
US20030040492A1 (en) 2003-02-27
HUP0204546A2 (en) 2003-05-28
DE60107544D1 (de) 2005-01-05
WO2001064225A1 (en) 2001-09-07
DE60107544T2 (de) 2005-12-15
AU2001231746B2 (en) 2004-12-23
ZA200207849B (en) 2003-12-30
AU3174601A (en) 2001-09-12
HUP0204546A3 (en) 2003-10-28
ATE283697T1 (de) 2004-12-15
AR027968A1 (es) 2003-04-16
AU2001231746C1 (en) 2005-10-06
CN1422158A (zh) 2003-06-04
BR0108828A (pt) 2002-12-10
CN1243551C (zh) 2006-03-01
HK1051650A1 (en) 2003-08-15
ES2232591T3 (es) 2005-06-01
JP2003533438A (ja) 2003-11-11
KR20020081375A (ko) 2002-10-26
PL365136A1 (en) 2004-12-27
EP1261355B1 (en) 2004-12-01
JP4838477B2 (ja) 2011-12-14
US7101553B2 (en) 2006-09-05
UA73763C2 (en) 2005-09-15
NO20024011D0 (no) 2002-08-22

Similar Documents

Publication Publication Date Title
PT1261355E (pt) Formulacao de hidrato de carbono (adjuvante prebiotico) para aumentar a resposta imune
DE60131335D1 (de) Hebelsteckverbinder
ATE521270T1 (de) Gegenstand zum reinigen
DE60110982D1 (de) Wasserdichter Verbinder
DE60110559D1 (de) Federbein mit komprimierbarem fluidum
DK1265633T3 (da) Vaccineadjuvans
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
NO20023367D0 (no) Glyburide-preparat
DK1199356T4 (da) Højproduktive alpha-amylaser
FR2807223B1 (fr) Connecteur
DE60109529D1 (de) Wasserdichter Steckverbinder
DE60104743D1 (de) Hebelsteckverbinder
HUP0302612A3 (en) Salmonella vaccine
DE60101415D1 (de) Hebelsteckverbinder
DE50105672D1 (de) Telemedizin-System
DE60139756D1 (de) Hebelsteckverbinder
GB2361782B (en) Improvements relating to computer systems
DE60105533D1 (de) Wasserdichter Verbinder
NO20024255L (no) HIV-immun adjuvansterapi
FI20000504A0 (fi) Järjestely tiedon siirtämiseksi muuntajassa
DE60117388D1 (de) Nahrungsergänzungsmittel
NO20010590L (no) Syklon
DE60107327D1 (de) Anschlussteil
NO20002110L (no) Fingerstyrt datamaskin-mus
DE60133509D1 (de) Federanschluss